New York State Common Retirement Fund
CMPX icon

New York State Common Retirement Fund’s Compass Therapeutics CMPX Stock Holding History

New York State Common Retirement Fund’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Hold
30,407
– – ﹤0.01% 2322
2025
Q4 		$163K Hold
30,407
– – ﹤0.01% 2371
2025
Q3 		$106K Hold
30,407
– – ﹤0.01% 2590
2025
Q2 		$79.1K Hold
30,407
– – ﹤0.01% 2807
2025
Q1 		$57.8K Sell
30,407
-7,800
-20% -$20.7K ﹤0.01% 2724
2024
Q4 		$55.4K Hold
38,207
– – ﹤0.01% 2829
2024
Q3 		$70.3K Hold
38,207
– – ﹤0.01% 2748
2024
Q2 		$38.2K Buy
38,207
+130
+0.3% +$190 ﹤0.01% 3145
2024
Q1 		$75.4K Sell
38,077
-104
-0.3% -$180 ﹤0.01% 2846
2023
Q4 		$59.6K Sell
38,181
-180
-0.5% -$311 ﹤0.01% 2942
2023
Q3 		$75.6K Buy
38,361
+961
+3% +$2.38K ﹤0.01% 2861
2023
Q2 		$119K Buy
+37,400
New +$117K ﹤0.01% 2712

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

New York State Common Retirement Fund's CMPX Position: Q1 2026 in Review

New York State Common Retirement Fund held its Compass Therapeutics (CMPX) position steady in Q1 2026 at 30,407 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

New York State Common Retirement Fund first reported a position in CMPX in Q2 2023 and has held it in 12 quarters since. The position peaked at $163K in Q4 2025. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • New York State Common Retirement Fund held 30,407 shares of Compass Therapeutics worth $161K as of Q1 2026.
  • New York State Common Retirement Fund left its Compass Therapeutics share count unchanged in Q1 2026.
  • Compass Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2322 holding.
  • New York State Common Retirement Fund first reported a position in Compass Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • New York State Common Retirement Fund's Compass Therapeutics position peaked at $163K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.